Now, eight years later, Chris credits the treatment with saving his life, calling it nothing short of miraculous. Another ...
New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...
Hosted on MSN12h
New First-Line Option for Advanced ALK-Positive Lung CancerThe FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK-positive locally advanced or metastatic ...
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...
Coherus BioSciences, Inc. ("Coherus,” NASDAQ: CHRS) today announced that an abstract highlighting final clinical and biomarker data from its Phase 2 clinical trial evaluating casdozokitug (casdozo), a ...
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback